Post Profile






Expensive hepatitis C drugs carry potentially deadly side effect, FDA warns

The Food and Drug Administration is requiring that its most serious warning be placed on high-profile drugs for treating hepatitis C, saying they can cause a reactivation of hepatitis B and subsequently have led to death in some patients. The direct-acting antiviral drugs – which include medicines under the brand names Sovaldi and Harvoni, as well as seven others – have high list prices that state governments, the Department of Veterans Affairs and prison systems have struggled to afford, with Sovaldi and Harvoni specifically costing tens of thousands of dollars for a full treatment.
read more

share
See more about: Drug Administration

Related Posts


Propecia Problems: Baldness Drug Linked with Long-Lasting Sexual Side Effects

Health : Time: Healthland

In April, the Food and Drug Administration (FDA) updated the warning to finasteride, Merck & Co.’s drug marketed to treat both male pattern baldness (Propecia) and enlarged prostate (Proscar). The new warnings noted that the sexual ...

FDA Adds Sexual Side Effects to Propecia and Proscar Labels

Health : Time: Healthland

The Food and Drug Administration (FDA) added new warnings on Wednesday to finasteride, the drug used to treat male pattern baldness and enlarged prostate, citing sexual side effects that continue to occur even after patients stop th...

Fake And Substandard Drugs Entering Legitimate US Supply Chain, Authorities Warn

Health : Medical News Today

A preliminary report warns of potentially serious threats to the legitimate US drug supply chain of counterfeit and substandard drugs, say the FDA (Food and Drug Administration), NABP (National Association of Boards of Pharmacy) and...

Warning By FDA Against High Dose Antidepressant Prescription May Be Unwarranted

Health : Medical News Today

The U.S. Food and Drug Administration's warning that high doses of the antidepressant citalopram can cause potentially serious abnormal heart rhythms might be doing more harm than good. In 2011, the FDA attached a warning to the dru...

After patient deaths, FDA warns about liver damage risk of hepatitis C medications

Health : The Checkup

Federal regulators on Thursday warned that two hepatitis C medications from drug maker AbbVie can cause "serious liver injury" in patients with advanced forms of the disease.The Food and Drug Administration said it had received nume...

Comments


Copyright © 2016 Regator, LLC